Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Food Allergy Market Snapshot (2023 to 2033)

The global food allergy market is likely to reach a valuation of US$ 39.83 Billion in 2023 and is expected to register at a CAGR of 5.2% to reach US$ 66.15 Billion by the end of 2033. By 2023, adrenaline treatment will account for almost 32% of the global market for food allergy treatments.

A large percentage of children and adults suffer from food allergies, with 8% of them being under five years old, and 4% being adults. Even though there is no cure for food allergies, some children outgrow them as they grow up and become more independent.

To assess and manage allergen hazards in food, the FDA offers guidance to food producers, consumers, and other stakeholders. Inspections and sampling by the FDA are also performed to ensure food products are properly labeled for major allergens in addition to ensuring food facilities implement controls to prevent cross-contact of allergens during manufacturing and packaging and that labeling controls prevent undeclared allergens.

A recall is initiated by the FDA after problems with products are found and public notification is provided to alert consumers. In addition to this, the FDA has the power to seize, remove, and refuse to allow the entry of products that violate its regulations from the marketplace, as well as deny imports entry into the country.

Data Points Key Statistics
Anticipated Base Year Value (2022) US$ 38 Billion
Expected Market Value (2023) US$ 39.83 Billion
Projected Forecast Value (2033) US$ 66.15 Billion
Global Growth Rate (2023 to 2033) 5.2% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of Food Allergy (2018 to 2022) Vs. Market Forecast Outlook (2023 to 2033)

According to FMI, food allergy sales grew at a CAGR of 4.8% in the historical period 2018 to 2022. Kids are increasingly suffering from food allergies, which is the latest epidemic of the current generation.

Several allergen-specific and non-specific therapies are under investigation as potential treatment options for people suffering from food allergies; however, in terms of therapeutic outcomes, immunotherapy has been identified as the most promising treatment option for individuals who suffer from food allergies to date. Providing an overview of recent developments in the treatment of food allergies is the objective of this review.

Anaphylaxis is still an unpredictable possibility with food allergies, which continue to increase in prevalence. There are fewer treatment options available, even though diagnostic accuracy is improving. Allergy management relies on avoiding offending allergens and educating patients on how to manage them. Although precautions and vigilance are taken, accidental ingesting continues.

Recent advancements made in the study of humoral and cellular immune responses and tolerance mechanisms in food allergy have led to the development of several therapeutic strategies to treat food allergies in an effort to cure or remit them long term. Accordingly, the market for food allergy is projected to grow at a CAGR of 5.2% between 2023 and 2033.

What Factors are driving High Demand for Food Allergies Treatment Worldwide?

According to research, asthma incidences are expected to rise from 2023 to 2033. Allergies to food commonly coexist with asthma. There is a greater likelihood that food allergies and asthma symptoms will become severe under these circumstances. The food allergy market growth rate is also influenced by rising healthcare expenditures that help improve its infrastructure. The government is also increasing funding for healthcare infrastructure, which will impact the dynamics of the market even further.

Across the globe, both children and adults are experiencing an increase in food allergies. With the increase in allergic diseases, it is likely that the demand for preventative and therapeutic measures for food allergies will increase. Additionally, 2/5th of the overall demand for allergy care is likely to be driven by an increased focus on research and development to offer advanced products to consumers.

In recent years, there has been an increase in allergies and awareness about food disorders that has forced the food industry and restaurants to follow regulatory norms in order to serve the nation. Gluten-free and dairy-free foods are an increase in demand on the market because both dietary programs and increasing awareness of food allergies among consumers have contributed to this demand.

Modern Medicine's Approach to Treat Food Allergies

The number of activities involved in research and development has increased over the past few years. Furthermore, the expansion of the market is largely due to the increased participation in research and development activities in the market. As a result, the food allergy market will have many opportunities for growth in the future. Drug approvals and launches will continue to drive the market's growth.

Food allergy market growth will also be positively impacted by increased investment in modern technologies and the emergence of new markets. In recent years, there has been a great deal of progress in understanding immunological mechanisms behind allergic disease, as well as a great deal of progress in identifying food allergens, which may lead to new therapeutic approaches. Researchers are currently looking into several forms of immunomodulation therapies, including peptide immunotherapy, mutant protein immunotherapy, allergy DNA vaccination, immunostimulatory DNA vaccination, and anti-immunoglobulin E (anti-IgE).

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Challenges Faced by the Food Allergy Market?

A lack of awareness regarding allergic conditions often leads to underdiagnosis and underestimation of these conditions, despite their high prevalence. In addition, inaccurate test results may negatively impact the growth of the food allergy market in the future.

A lack of uniformity in diagnostic criteria greatly limits the evidence for food allergy prevalence and management. Furthermore, the delay in the issuance of the results will negatively impact the growth of the market, as well as the fact that it involves a large volume of blood for multiple tests, which is hard for younger children and will hamper the growth.

A large price tag for the tests, as well as the absence of allergy tests, are the main concerns affecting the market. Despite this, organizations like the European Federation of Allergy and Airway Diseases Patients Associations (EFA) have introduced a lot of campaigns aimed at boosting food allergy awareness in the market.

Start-ups for Food Allergy Treatment

New Entrants Bring Positive Changes to the Food Allergy Landscape

New entrants are capitalizing on technological advances in the food allergy field to introduce new solutions and gain a competitive edge in the market. These companies constantly invest in research and development to stay ahead of changing consumer preferences. The company is striving to advance the food allergy market and improve its position in the forum.

  • Ready, Set, Food! Supplier of children's nutrition products. In addition to being organic and allergy-free, the company claims that its products are free of chemicals. In addition to breastfeeding and formula, it contains the top nine most common food allergies, including peanuts, eggs, milk, almonds, cashews, walnuts, soy, wheat, and sesame. Contains no GMOs and no sugar. Products are sold through the company's website.
  • Foods You Can- Founded in 2009, a website that provides information and comparisons of food prices for people with food intolerances, allergies, and other health issues. The firm has raised a total funding of $16K over 1 round. Their latest round of funding was a $10K angel round that was held on February 15, 2011.
  • OITWorks- Founded in 2014, OITWorks helps parents monitor their children's oral immunotherapy (OIT) treatment for severe food allergies using an iPhone application. In addition to organizing medication, doses, and rest times, the app enables users to customize their schedules.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Comparative View of Adjacent Food Allergy Markets          

Food Allergy Market:

Attributes Food Allergy Market
CAGR (2023 to 2033) 5.2%
Market Value (2033) US$ 66.15 Billion
Growth Factor An increase in the number of people with food allergies. Policy and regulations favorable to the public are expected to grow the market.
Opportunity With the increasing number of innovative products in the food allergen testing market, the forecast period is likely to be filled with explosive growth opportunities.

Allergy Treatment Market:

Attributes Allergy Treatment Market
CAGR (2023 to 2033) 6.3%
Market Value (2033) US$ 16.32 Billion
Growth Factor With the rise of self-medication, increasing healthcare expenditures, an aging population, the rise of government-sponsored educational programs, and rising chronic illness incidences, allergy treatment markets are expected to grow.
Opportunity A rising level of Research and Development and a greater understanding of immunotherapy as a treatment for allergies will open up profitable opportunities in the future.

Allergy Immunotherapy Market:

Attributes Allergy Immunotherapy Market
CAGR (2023 to 2033) 7.5%
Market Value (2033) US$ 2928.2 Million
Growth Factor Due to the rising prevalence of allergies worldwide, the allergy immunotherapy market is growing rapidly.
Opportunity With an increasing number of allergic rhinitis and asthma patients, allergy immunotherapy will continue to be a profitable market.

Regional Insights

Why is the North American Food Allergy Market Experiencing Significant Revenue Growth?

According to the forecast, North America is likely to account for 43% of global food allergy treatments. Several factors are responsible for this dominance, including a large number of patients, advancements in food allergy treatment, and a high level of awareness regarding food allergies and treatment.

The development of new food allergy treatments and the development of new drugs in the USA market will further widen the market for food allergy treatments. As a result of the recent approval of oral immunotherapy (OIT) by the Food and Drug Administration (FDA), patients with peanut allergies can now benefit from this treatment, while patients with mild reactions are not suitable for this treatment.

A study published in JAMA Network Open Journal found that 10.8% of adults in the survey were food allergic, while nearly 17% believed they were. Food allergies are prevalent among nearly half of the adult population, and 38% of them have been to an emergency room as a result of food allergies.

Researchers at the American College of Allergy, Asthma, and Immunology (ACAAI) published a study in the scientific journal Annals of Allergy, Asthma, and Immunology that found targeted cognitive behavioral therapy (CBT) to significantly reduce anxiety associated with food allergies (FAA).

How will the Food Allergy Treatment fare across Europe?

According to the estimate, the European region is expected to dominate the market. The revenue generated from this region accounts for 36% of the total revenue generated worldwide. Many people in the region suffer from allergies, which accounts for the region's dominance in the food allergy market. Food allergies affect over 150 million people worldwide, representing 20 percent of the region's population, according to the European Academy of Allergy and Clinical Immunology (EAACI).

Children and adults with food allergies are reported to be affected by food allergies at a rate ranging from 3-4%, respectively. Over 17 million Europeans suffer from allergies related to food, according to the European Academy of Allergy and Clinical Immunology. Over the past decade, the number of children who have been admitted to the hospital for severe reactions has increased by 7X.

In addition to minimizing the occurrence of food allergic reactions caused by undeclared allergens, the Joint Research Centre (JRC) of the European Commission has several other objectives. As Europeans become more aware of their allergies to certain foods and stricter compliance with regulatory requirements, the European food allergen testing market continues to grow.

Category-Wise Insights

What Allergen Source will expand the Fastest in the Next Few Years?

Based on allergen sources, the market is segmented into gluten, peanut, mustard, milk, egg, fish, and other food allergy market. FMI predicts that peanuts allergen sources will dominate the market throughout the projection period. Peanut food allergy dominates more than 25% of the market.

The increasing prevalence of peanut allergies is a major factor driving the peanut allergy market. Furthermore, research is steadily being conducted to develop individual allergen immunotherapies (AIT) that can help in achieving allergen neutralization in less time with minimal side effects. Additionally, pharma and biotech companies are strongly inclining toward discovering new immunotherapies for peanut allergy, which is significantly driving the market growth.

In recent years, peanut allergy treatment and management have advanced dramatically. To desensitize an individual to allergens, new research is exploring oral immunotherapy, which gradually increases the amount of allergen a person is exposed to. A number of studies have also been conducted investigating the potential reduction in peanut allergy risk by using probiotics, allergen-specific immunotherapy, and gene therapy. A new diagnostic test that is more accurate and less invasive will be developed, as well as biomarkers specific to peanut allergy that can be located.

Food allergies are not uncommon. Approximately 17 million Europeans suffer from food allergies each year, of whom 3.5 million are under 25 years old, according to the European Federation of Allergy and Airways Diseases Patients Associations (EFA). Most children are allergic to peanuts and peanut allergy is the most common cause of food allergy death.

How Oral Immunotherapy will develop Over the Coming Years?

Based on treatment type, the food allergy market is segmented into antihistamines treatment. The oral immunotherapy segment is expected to represent 22% of the market and grow at a CAGR of 3.6% during the evaluation period. Research and development efforts are being conducted for the trials to develop proven methods for maximizing benefits and minimizing potential harm.

A strict avoidance of confirmed food allergens is recommended for the management of food allergy until food allergy OIT and other treatments have been proven to be reliable, safe, standardized, and approved for routine use in Australia (TGA) or New Zealand (Medsafe).

In childhood and adolescence with peanut allergy (PA), oral immunotherapy with Palforzia (POIT) aims to mitigate accidental allergic reactions. This therapy is a relatively new approach, so it's hard to know how many patients and families will choose it over strict avoidance.

Market Competition

Several domestic and regional players participate in the global food allergy market, which is highly fragmented and competitive. Mergers and acquisitions, expansions, collaborations, and partnerships are among the marketing strategies used by key players.

A company's marketing strategy can also be upscaled by developing new products. The implementation of these strategies has led to the development of advanced food allergy products.

  • Vionic, FARE's new partner, supports education and research to benefit people with life-threatening food allergies. In the year-end campaign, Future Starts Now, FARE is targeting to raise $1 million to achieve its goal of raising $220,000. FARE and Vionic signed an official Partner Agreement in the fall of 2022. By collaborating with FARE, Vionic is improving the lives and health of people who suffer from food allergies. With this partnership, FARE will expand awareness and support of its strategic campaigns aimed at benefitting individuals with food allergies.
  • A new investor, Edward-Elmhurst Health, led a funding round for childhood food allergy prevention start-up Ready, Set, Food. In addition to Danone's corporate venture arm, Danone Manifesto Ventures, as well as entrepreneur Mark Cuban and AF Ventures (formerly AccelFoods), there are returning investors this year as well. After raising $3 million in July of last year, Ready, Set Food raised another $3 million in less than a year.

Report Scope

Report Attribute Details
Market Value in 2023 US$ 39.83 Billion
Market Value in 2033 US$ 66.15 Billion
Growth Rate CAGR of 5.2% from 2022 to 2032
Base Year for Estimation 2022
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in US$ Billion and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
  • Allergen Source
  • Treatment
  • End Use
  • Region
Regions Covered
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Key Countries Profiled
  • USA
  • Canada
  • Brazil
  • Mexico
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • Singapore
  • Thailand
  • Indonesia
  • Australia
  • New Zealand
  • GCC
  • South Africa
  • Israel
Key Companies Profiled
  • Allergy Therapeutics
  • Astellas Pharma Inc.
  • Immunomic Therapeutics Inc.
  • Prota Therapeutics
  • Aimmune Therapeutics
  • Aravex
  • Cambridge Allergy Ltd.
  • ALS Limited
  • Charm Sciences
  • Danaher Corporation
Customization Available Upon Request

Key Segments Profiled in the Food Allergy Industry Survey

Food Allergy Market by Allergen Source:

  • Gluten
  • Peanut
  • Mustard
  • Milk
  • Egg
  • Fish
  • Others

Food Allergy Market by Treatment:

  • Antihistamines
  • Adrenaline
  • Oral Immunotherapy
  • Others

Food Allergy Market by End Use:

  • Clinics
  • Hospitals
  • Ambulatory Surgery Centers

Food Allergy Market by Region:

  • North America Food Allergy Market
  • Latin America Food Allergy Market
  • Europe Food Allergy Market
  • Asia Pacific Food Allergy Market
  • Middle East & Africa Food Allergy Market

Frequently Asked Questions

What was the market worth for food allergy in 2022?

The food allergy market was worth US$ 38 Billion in 2022

What's the projected value of the food allergy industry by 2023?

According to FMI, the food allergy market will reach US$ 39.83 Billion by 2023.

At what percentage will the market for food allergy rise until 2033?

From 2023 to 2033, FMI expects food allergy revenue to flourish at a 5.2% CAGR

What is the expected market value for food allergy in 2033?

In 2033, the food allergy market worth is poised to reach US$ 66.15 Billion

How do growth prospects for food allergy appear in North America?

The North American market is expected to dominate the industry in 2023, accounting for more than 43% of overall revenues.

How do growth prospects for food allergy appear in the Europe?

The food allergy market in Europe is expected to grow at a market share of 36% by 2033.

Who are the top 5 market players in the food allergy market?

Allergy Therapeutics, Astellas Pharma, Inc., Immunomic Therapeutics, Inc., Prota Therapeutics, and Aimmune Therapeutics are the top 5 market players in the food allergy market.

What is the outlook for food allergy in Asia Pacifc?

According to forecasts, by 2032 food allergy sales in Asia Pacific will reach a market share of 22% during the forecast period.

Table of Content

1. Executive Summary | Food Allergy Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Allergen Source

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Allergen Source, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Allergen Source, 2023 to 2033

        5.3.1. Gluten

        5.3.2. Peanut

        5.3.3. Mustard

        5.3.4. Milk

        5.3.5. Egg

        5.3.6. Fish

        5.3.7. Others

    5.4. Y-o-Y Growth Trend Analysis By Allergen Source, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Allergen Source, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Treatment

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Treatment, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment, 2023 to 2033

        6.3.1. Antihistamines

        6.3.2. Adrenaline

        6.3.3. Oral Immunotherapy

        6.3.4. Others

    6.4. Y-o-Y Growth Trend Analysis By Treatment, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Treatment, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-use

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2023 to 2033

        7.3.1. Clinics

        7.3.2. Hospitals

        7.3.3. Ambulatory Surgery Centers

    7.4. Y-o-Y Growth Trend Analysis By End-use, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By End-use, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. Middle East and Africa (MEA)

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. United States of America

            9.2.1.2. Canada

        9.2.2. By Allergen Source

        9.2.3. By Treatment

        9.2.4. By End-use

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Allergen Source

        9.3.3. By Treatment

        9.3.4. By End-use

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Allergen Source

        10.2.3. By Treatment

        10.2.4. By End-use

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Allergen Source

        10.3.3. By Treatment

        10.3.4. By End-use

    10.4. Key Takeaways

11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United Kingdom

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Allergen Source

        11.2.3. By Treatment

        11.2.4. By End-use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Allergen Source

        11.3.3. By Treatment

        11.3.4. By End-use

    11.4. Key Takeaways

12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

            12.2.1.4. Singapore

            12.2.1.5. Thailand

            12.2.1.6. Indonesia

            12.2.1.7. Australia

            12.2.1.8. New Zealand

            12.2.1.9. Rest of Asia Pacific

        12.2.2. By Allergen Source

        12.2.3. By Treatment

        12.2.4. By End-use

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Allergen Source

        12.3.3. By Treatment

        12.3.4. By End-use

    12.4. Key Takeaways

13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. GCC Countries

            13.2.1.2. South Africa

            13.2.1.3. Israel

            13.2.1.4. Rest of MEA

        13.2.2. By Allergen Source

        13.2.3. By Treatment

        13.2.4. By End-use

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Allergen Source

        13.3.3. By Treatment

        13.3.4. By End-use

    13.4. Key Takeaways

14. Key Countries Market Analysis

    14.1. United States of America

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2022

            14.1.2.1. By Allergen Source

            14.1.2.2. By Treatment

            14.1.2.3. By End-use

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2022

            14.2.2.1. By Allergen Source

            14.2.2.2. By Treatment

            14.2.2.3. By End-use

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2022

            14.3.2.1. By Allergen Source

            14.3.2.2. By Treatment

            14.3.2.3. By End-use

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2022

            14.4.2.1. By Allergen Source

            14.4.2.2. By Treatment

            14.4.2.3. By End-use

    14.5. Germany

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2022

            14.5.2.1. By Allergen Source

            14.5.2.2. By Treatment

            14.5.2.3. By End-use

    14.6. United Kingdom

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2022

            14.6.2.1. By Allergen Source

            14.6.2.2. By Treatment

            14.6.2.3. By End-use

    14.7. France

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2022

            14.7.2.1. By Allergen Source

            14.7.2.2. By Treatment

            14.7.2.3. By End-use

    14.8. Spain

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2022

            14.8.2.1. By Allergen Source

            14.8.2.2. By Treatment

            14.8.2.3. By End-use

    14.9. Italy

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2022

            14.9.2.1. By Allergen Source

            14.9.2.2. By Treatment

            14.9.2.3. By End-use

    14.10. China

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2022

            14.10.2.1. By Allergen Source

            14.10.2.2. By Treatment

            14.10.2.3. By End-use

    14.11. Japan

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2022

            14.11.2.1. By Allergen Source

            14.11.2.2. By Treatment

            14.11.2.3. By End-use

    14.12. South Korea

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2022

            14.12.2.1. By Allergen Source

            14.12.2.2. By Treatment

            14.12.2.3. By End-use

    14.13. Singapore

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2022

            14.13.2.1. By Allergen Source

            14.13.2.2. By Treatment

            14.13.2.3. By End-use

    14.14. Thailand

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2022

            14.14.2.1. By Allergen Source

            14.14.2.2. By Treatment

            14.14.2.3. By End-use

    14.15. Indonesia

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2022

            14.15.2.1. By Allergen Source

            14.15.2.2. By Treatment

            14.15.2.3. By End-use

    14.16. Australia

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2022

            14.16.2.1. By Allergen Source

            14.16.2.2. By Treatment

            14.16.2.3. By End-use

    14.17. New Zealand

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2022

            14.17.2.1. By Allergen Source

            14.17.2.2. By Treatment

            14.17.2.3. By End-use

    14.18. GCC Countries

        14.18.1. Pricing Analysis

        14.18.2. Market Share Analysis, 2022

            14.18.2.1. By Allergen Source

            14.18.2.2. By Treatment

            14.18.2.3. By End-use

    14.19. South Africa

        14.19.1. Pricing Analysis

        14.19.2. Market Share Analysis, 2022

            14.19.2.1. By Allergen Source

            14.19.2.2. By Treatment

            14.19.2.3. By End-use

    14.20. Israel

        14.20.1. Pricing Analysis

        14.20.2. Market Share Analysis, 2022

            14.20.2.1. By Allergen Source

            14.20.2.2. By Treatment

            14.20.2.3. By End-use

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Allergen Source

        15.3.3. By Treatment

        15.3.4. By End-use

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. Allergy Therapeutics

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segments

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

        16.1.2. Astellas Pharma, Inc.

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segments

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

        16.1.3. Immunomic Therapeutics, Inc.

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segments

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

        16.1.4. Prota Therapeutics

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segments

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

        16.1.5. Aimmune Therapeutics

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segments

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

        16.1.6. Aravax

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segments

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

        16.1.7. Cambridge Allergy Ltd

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segments

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

        16.1.8. ALS Limited

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segments

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

        16.1.9. Charm Sciences

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segments

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

        16.1.10. Danaher Corporation

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segments

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Allergen Source, 2018 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Treatment, 2018 to 2033

Table 4: Global Market Value (US$ Million) Forecast by End-use, 2018 to 2033

Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Allergen Source, 2018 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Treatment, 2018 to 2033

Table 8: North America Market Value (US$ Million) Forecast by End-use, 2018 to 2033

Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 10: Latin America Market Value (US$ Million) Forecast by Allergen Source, 2018 to 2033

Table 11: Latin America Market Value (US$ Million) Forecast by Treatment, 2018 to 2033

Table 12: Latin America Market Value (US$ Million) Forecast by End-use, 2018 to 2033

Table 13: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 14: Europe Market Value (US$ Million) Forecast by Allergen Source, 2018 to 2033

Table 15: Europe Market Value (US$ Million) Forecast by Treatment, 2018 to 2033

Table 16: Europe Market Value (US$ Million) Forecast by End-use, 2018 to 2033

Table 17: Asia Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 18: Asia Pacific Market Value (US$ Million) Forecast by Allergen Source, 2018 to 2033

Table 19: Asia Pacific Market Value (US$ Million) Forecast by Treatment, 2018 to 2033

Table 20: Asia Pacific Market Value (US$ Million) Forecast by End-use, 2018 to 2033

Table 21: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 22: MEA Market Value (US$ Million) Forecast by Allergen Source, 2018 to 2033

Table 23: MEA Market Value (US$ Million) Forecast by Treatment, 2018 to 2033

Table 24: MEA Market Value (US$ Million) Forecast by End-use, 2018 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Allergen Source, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Treatment, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by End-use, 2023 to 2033

Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 8: Global Market Value (US$ Million) Analysis by Allergen Source, 2018 to 2033

Figure 9: Global Market Value Share (%) and BPS Analysis by Allergen Source, 2023 to 2033

Figure 10: Global Market Y-o-Y Growth (%) Projections by Allergen Source, 2023 to 2033

Figure 11: Global Market Value (US$ Million) Analysis by Treatment, 2018 to 2033

Figure 12: Global Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033

Figure 13: Global Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033

Figure 14: Global Market Value (US$ Million) Analysis by End-use, 2018 to 2033

Figure 15: Global Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033

Figure 16: Global Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033

Figure 17: Global Market Attractiveness by Allergen Source, 2023 to 2033

Figure 18: Global Market Attractiveness by Treatment, 2023 to 2033

Figure 19: Global Market Attractiveness by End-use, 2023 to 2033

Figure 20: Global Market Attractiveness by Region, 2023 to 2033

Figure 21: North America Market Value (US$ Million) by Allergen Source, 2023 to 2033

Figure 22: North America Market Value (US$ Million) by Treatment, 2023 to 2033

Figure 23: North America Market Value (US$ Million) by End-use, 2023 to 2033

Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 28: North America Market Value (US$ Million) Analysis by Allergen Source, 2018 to 2033

Figure 29: North America Market Value Share (%) and BPS Analysis by Allergen Source, 2023 to 2033

Figure 30: North America Market Y-o-Y Growth (%) Projections by Allergen Source, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Treatment, 2018 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by End-use, 2018 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033

Figure 37: North America Market Attractiveness by Allergen Source, 2023 to 2033

Figure 38: North America Market Attractiveness by Treatment, 2023 to 2033

Figure 39: North America Market Attractiveness by End-use, 2023 to 2033

Figure 40: North America Market Attractiveness by Country, 2023 to 2033

Figure 41: Latin America Market Value (US$ Million) by Allergen Source, 2023 to 2033

Figure 42: Latin America Market Value (US$ Million) by Treatment, 2023 to 2033

Figure 43: Latin America Market Value (US$ Million) by End-use, 2023 to 2033

Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 48: Latin America Market Value (US$ Million) Analysis by Allergen Source, 2018 to 2033

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Allergen Source, 2023 to 2033

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Allergen Source, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) Analysis by Treatment, 2018 to 2033

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) Analysis by End-use, 2018 to 2033

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033

Figure 57: Latin America Market Attractiveness by Allergen Source, 2023 to 2033

Figure 58: Latin America Market Attractiveness by Treatment, 2023 to 2033

Figure 59: Latin America Market Attractiveness by End-use, 2023 to 2033

Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 61: Europe Market Value (US$ Million) by Allergen Source, 2023 to 2033

Figure 62: Europe Market Value (US$ Million) by Treatment, 2023 to 2033

Figure 63: Europe Market Value (US$ Million) by End-use, 2023 to 2033

Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 68: Europe Market Value (US$ Million) Analysis by Allergen Source, 2018 to 2033

Figure 69: Europe Market Value Share (%) and BPS Analysis by Allergen Source, 2023 to 2033

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Allergen Source, 2023 to 2033

Figure 71: Europe Market Value (US$ Million) Analysis by Treatment, 2018 to 2033

Figure 72: Europe Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033

Figure 74: Europe Market Value (US$ Million) Analysis by End-use, 2018 to 2033

Figure 75: Europe Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033

Figure 76: Europe Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033

Figure 77: Europe Market Attractiveness by Allergen Source, 2023 to 2033

Figure 78: Europe Market Attractiveness by Treatment, 2023 to 2033

Figure 79: Europe Market Attractiveness by End-use, 2023 to 2033

Figure 80: Europe Market Attractiveness by Country, 2023 to 2033

Figure 81: Asia Pacific Market Value (US$ Million) by Allergen Source, 2023 to 2033

Figure 82: Asia Pacific Market Value (US$ Million) by Treatment, 2023 to 2033

Figure 83: Asia Pacific Market Value (US$ Million) by End-use, 2023 to 2033

Figure 84: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033

Figure 85: Asia Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 88: Asia Pacific Market Value (US$ Million) Analysis by Allergen Source, 2018 to 2033

Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Allergen Source, 2023 to 2033

Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Allergen Source, 2023 to 2033

Figure 91: Asia Pacific Market Value (US$ Million) Analysis by Treatment, 2018 to 2033

Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033

Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033

Figure 94: Asia Pacific Market Value (US$ Million) Analysis by End-use, 2018 to 2033

Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033

Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033

Figure 97: Asia Pacific Market Attractiveness by Allergen Source, 2023 to 2033

Figure 98: Asia Pacific Market Attractiveness by Treatment, 2023 to 2033

Figure 99: Asia Pacific Market Attractiveness by End-use, 2023 to 2033

Figure 100: Asia Pacific Market Attractiveness by Country, 2023 to 2033

Figure 101: MEA Market Value (US$ Million) by Allergen Source, 2023 to 2033

Figure 102: MEA Market Value (US$ Million) by Treatment, 2023 to 2033

Figure 103: MEA Market Value (US$ Million) by End-use, 2023 to 2033

Figure 104: MEA Market Value (US$ Million) by Country, 2023 to 2033

Figure 105: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 106: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 107: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 108: MEA Market Value (US$ Million) Analysis by Allergen Source, 2018 to 2033

Figure 109: MEA Market Value Share (%) and BPS Analysis by Allergen Source, 2023 to 2033

Figure 110: MEA Market Y-o-Y Growth (%) Projections by Allergen Source, 2023 to 2033

Figure 111: MEA Market Value (US$ Million) Analysis by Treatment, 2018 to 2033

Figure 112: MEA Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033

Figure 113: MEA Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033

Figure 114: MEA Market Value (US$ Million) Analysis by End-use, 2018 to 2033

Figure 115: MEA Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033

Figure 116: MEA Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033

Figure 117: MEA Market Attractiveness by Allergen Source, 2023 to 2033

Figure 118: MEA Market Attractiveness by Treatment, 2023 to 2033

Figure 119: MEA Market Attractiveness by End-use, 2023 to 2033

Figure 120: MEA Market Attractiveness by Country, 2023 to 2033

Recommendations

Healthcare

Allergy Immunotherapy Market

Published : March 2023

Healthcare

Allergy Diagnostics Market

Published : December 2022

Healthcare

Allergy Treatment Market

Published : November 2022

Explore Healthcare Insights

View Reports